Claims
- 1. The process of preparing a cured, crosslinked polymer membrane or filament having a high glass transition temperature above 150.degree. C. prepared from between about 70 and 100 wt. % N-vinyl lactam monomer having 4 or 6 ring carbon atoms in its heterocyclic structure or a mixture of said N-vinyl lactam monomers and between 0 and about 30 wt. % olefinically unsaturated comonomer which comprises
- (1) forming a uniform liquid mixture of
- (a) between about 2 and about 30 wt. % of said monomer or monomers;
- (b) between about 0.01 and about 10.0 wt. % crosslinking agent and
- (c) between about 60 and about 90 wt. % water;
- (2) in an inert atmosphere, polymerizing the mixture under agitation in the presence of a free radical polymerization initiator by heating the mixture to between about 50.degree. and about 80.degree. C. for a period of from about 2 to about 5 hours and until a constant viscosity of from about 60 to about 100 K value is obtained;
- (3) applying a coating of the resulting soluble polymer as a film to a substrate or extruding the soluble polymer in the form of a filament;
- (4) subjecting said film or filament to curing in a closed system in an inert atmosphere at a temperature of from about 100.degree. to about 140.degree. C. for a period of from about 0.5 to about 3 hours to produce a transparent, water insoluble formed product and then
- (5) digesting the formed product in water to swell the polymer and extract soluble monomer and linear polymer so as to form a stable hydrogel as a continuous membrane or filament.
- 2. The process of claim 1 wherein step (5) is effected by continual removal and replacement of water.
- 3. The process of claim 1 wherein from about 0.1 to about 5 wt. % cross-linking agent is employed.
- 4. The process of claim 3 wherein between about 2 and about 30 wt. % of N-vinylpyrrolidone monomer is employed with between about 0 1 and about 5 wt. % of 1-vinyl-3(E) ethylene pyrrolidone crosslinking agent.
- 5. The process of claim 1 wherein said initiator is t-butylperoxy pivalate.
- 6. The process of claim 1 wherein the cured formed product of step (4) is digested in from 1 to 500 volumes of water.
- 7. The process of claim 6 wherein the cured formed product of step (4) is digested in from 50 to 150 volumes of water.
- 8. The process of claim 1 wherein an effective disinfecting amount of an antiseptic is added to the mixture of step (1).
Parent Case Info
This is a division of application Ser. No. 08/103,944, filed Aug. 9, 1993.
US Referenced Citations (4)
Divisions (1)
|
Number |
Date |
Country |
Parent |
103944 |
Aug 1993 |
|